NCT02612480View on ClinicalTrials.gov

Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Endotoxemia
Interventions
DRUG

ticagrelor

7 day treatment of ticagrelor 2dd90mg after a loading dose of 180mg

DRUG

Clopidogrel

7 day treatment of clopidogrel 1d75mg after a loading dose of 300mg

DRUG

Acetylsalicylic acid lysinate

7 day treatment of acetylsalicyclic acid 1d80mg after a loading dose of 160mg

DRUG

Placebo

7 day treatment with placebo

Trial Locations (1)

6500HB

Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02612480 - Ticagrelor in Human Endotoxemia Response to Human Endotoxemia | Biotech Hunter | Biotech Hunter